Extracorporeal carbon dioxide removal (ml/min) at different blood flows and different membrane lung surfaces. It is clear that, at low blood flow (250 ml/min) and small surface (very often extracorporeal carbon dioxide removal–Continuous Renal Replacement Therapy combined systems), the darboxilating capacity of the device is fairly low. Reprinted with permission from Karagiannidis et al.³⁴